Important Resolutions of the Company's 2022 General Shareholders' Meeting
· Issued by TaiMed Biologics Inc.
Close
Today's Information
Provided by: TaiMed Biologics Inc.
SEQ_NO
4
Date of announcement
2022/05/30
Time of announcement
15:49:23
Subject
Important Resolutions of the Company's 2022
General Shareholders' Meeting
Date of events
2022/05/30
To which item it meets
paragraph 18
Statement
1.Date of the shareholders' meeting:2022/05/30
2.Important resolutions I.Profit distribution/deficit compensation:
Acknowledgment of the 2021 deficit compensation
3.Important resolutions II.Amendments of the company charter:
Approved the amendments of the company charter
4.Important resolutions III.Business report and financial statements:
Acknowledgment of the 2021 business report and financial statements
5.Important resolutions IV.Election for directors and supervisors:
The list of persons elected as belows:
Newly-appointed directors:
(1) James Chang
(2) Hui-Chuan, Chang(Representative of National Development Fund)
(3) Shih Chia Lin(Representative of National Development Fund)
(4) Frank Chen(Representative of Chang Chun Investment)
(5) Tien-Chieh, Lee(Representative of Huei Hong Investment)
(6) Tamon Tseng(Representative of Yi Tai Investment)
Newly-appointed independent directors:
(7) Chin-Ting, Chiu
(8) Howard S. Lee
(9) Gwo-Fong, Lin
6.Important resolutions V.Other matters:
(1) Approved the amendment to the Operational procedures for Acquisition and
Disposal of Assets.
(2) Approved the lifting of non-competition restrictions for directors.
7.Any other matters that need to be specified:None
